<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02881723</url>
  </required_header>
  <id_info>
    <org_study_id>2012-25</org_study_id>
    <secondary_id>2012-A00863-40</secondary_id>
    <nct_id>NCT02881723</nct_id>
  </id_info>
  <brief_title>Obstructive Sleep Apnea Syndrome After Oropharyngeal Cancer Treatment</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The level of knowledge about the consequences of oropharyngeal cancer treatment on sleep&#xD;
      quality remains poor. Because of a high level of risk of developing an Obstructive Sleep&#xD;
      Apnea Syndrome (OSAS), an accurate evaluation of the prevalence, of the risk factors and of&#xD;
      the impact on quality of life is important in order to propose preventive and therapeutic&#xD;
      solutions to these patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Obstructive sleep apnea syndrome (OSAS) remains poorly documented in head and neck cancer&#xD;
      cancer population, who have a higher risk than the general population. OSAS is a risk factor&#xD;
      for quality of life impairment and cardiovascular morbidity and mortality.&#xD;
&#xD;
      This study proposes to carry out an OSAS prevalence study among a locally advanced head and&#xD;
      neck cancer population, already treated and to compare the consequences of current&#xD;
      therapeutic options in sleep quality.The primary research objective will be a prevalence&#xD;
      determination in a locally advanced stages treated population of oropharyngeal cancer.&#xD;
      Secondary objectives will be the comparison of the prevalence between the surgical group and&#xD;
      the radio-chemotherapy group, the research of predictive factors of presenting an OSAS and&#xD;
      the precision of the impact on quality of life.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measuring the index of apneas and hypopneas (IAH), defined by the number of apneas per sleep hour</measure>
    <time_frame>1 day</time_frame>
    <description>For an IAH &lt;10: no Obstructive Sleep Apnea Syndrome (OSAS) For an IAH&gt;30: severe OSAS is diagnosed</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <condition>Oropharyngeal Cancer</condition>
  <arm_group>
    <arm_group_label>Treatment for oropharyngeal cancer by surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Disease-free patients treated for locally advanced oropharyngeal cancer for over 12 months by surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment for oropharyngeal cancer by radio-chemotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Disease-free patients treated for locally advanced oropharyngeal cancer for over 12 months by radio-chemotherapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Surgery</intervention_name>
    <arm_group_label>Treatment for oropharyngeal cancer by surgery</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Radio- chemotherapy</intervention_name>
    <arm_group_label>Treatment for oropharyngeal cancer by radio-chemotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient aged over 18 years old, male or female;&#xD;
&#xD;
          -  Patient treated for a first oropharyngeal cancer located in upper airways (velum, side&#xD;
             walls, back wall, base of tongue, vallecules), locally advanced, rated T3 or T4,&#xD;
             whatever the stage N and M0;&#xD;
&#xD;
          -  Patient who received curative treatment either surgical (excision and reconstruction&#xD;
             free flap) with adjuvant radiotherapy or concurrent chemoradiotherapy;&#xD;
&#xD;
          -  Treatment completed at least 12 months prior to study entry;&#xD;
&#xD;
          -  Patient whose cancer disease is under control at exam time;&#xD;
&#xD;
          -  Subject affiliated to a social security scheme;&#xD;
&#xD;
          -  Subject agreeing to participate in the study and who signed the informed consent form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Minor patient&#xD;
&#xD;
          -  No affiliation to a social security scheme (beneficiary or assignee);&#xD;
&#xD;
          -  Patient who did not signed the informed consent form&#xD;
&#xD;
          -  Patient with neurological disease that can affect the upper airways function&#xD;
&#xD;
          -  Patient has already been treated for head and neck cancer;&#xD;
&#xD;
          -  Patient has a lesion classified T1 or T2 or M1;&#xD;
&#xD;
          -  Patient has received different treatments: surgical resection without reconstruction,&#xD;
             only radiotherapy&#xD;
&#xD;
          -  Unweaned alcoholic patients&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine GEINDRE</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hôpitaux de Marseille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Service d'ORL et de Chirurgie Cervico-Faciale - Hôpital de la Timone, AP-HM</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>August 24, 2016</study_first_submitted>
  <study_first_submitted_qc>August 24, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2016</study_first_posted>
  <last_update_submitted>August 24, 2016</last_update_submitted>
  <last_update_submitted_qc>August 24, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oropharyngeal Neoplasms</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

